• Clip News: Display Concepts - Clip Distributor Completes a Stunning Exhibition Stand Design  Read More...
  • Clip News: Clip Stand confirmed at Institute of Fundraising November 23rd & 24th, a must for all Charity contacts, come & see us on stand number two!
  • Clip News: Just finalised a stand at World Travel Market for a long standing Clip user!
  • Clip News: The team at Clip are developing,maufacturing and installing a new contemporary brand awareness and hospitality area at its world leading leisure industry clients UK Headquarters
  • Customer comments: Great to hear this from one of our customers "I have not forgotten how useful Clip and your good self were whilst I was at Tensar/Carborundum”.  Our hardworking team did themselves credit...
  • Clip News: Finalised site plans for Shanghai Motor Show, penultimate leg of Saint-Gobains global event programme for 2011, great first year working with this new partner’
  • Clip News: Discussing brief for 12m x 10m stand with Clip in-house design dept for DUK March 2012
  • Clip News: Finalised plans for small stand and external branding at British Free Range Egg Producers Association Conf November 2011
  • Have you seen our online shop for exhibition supplies? View it here...
  • Clip News: Supporting a long standing client again at the Inter Airport Show in Munich by building a 60 square metre stand

Exhibition Stands News

AstraZeneca board member to retire in April

27 Feb 2009

Hakan Mogren, non-executive deputy chairman of AstraZeneca, is due to retire from the company''s board of directors at the end of the firm''s annual general meeting on April 30th, it has been announced.

Commenting on the move, Louis Schweitzer, chairman of the pharmaceutical firm, said Mr Mogren has made an "excellent" contribution in his roles as deputy chairman and chief executive officer of Astra AB.

He added that Mr Mogren was "instrumental" in the formation of AstraZeneca and brought both sound judgement and a wealth of experience to decisions taken by the board.

Mr Schweitzer concluded: "His fellow directors and I thank him for his distinguished contribution to the company over two decades and wish him a long and very happy retirement."

AstraZeneca recently announced its full-year results for 2008, stating "good headway" is being made in terms of improving the firm''s efficiency and sustaining its long-term competitiveness in the pharmaceutical sector.ADNFCR-2086-ID-19050467-ADNFCR